Delivery Order SPE2DB24D6044-SPE2DB25FLJKK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Omeprazole DR 40 mg capsules (90-count unit) on July 25, 2025, with a ceiling value of $1,083.09 and an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as...
- The Defense Logistics Agency awarded a delivery order valued at $11,597.84 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules (1,000 units) on August 14, 2025. This contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a $1,533.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of 500 capsules of Omeprazole DR 40 mg. This is a non-set-aside contract with an ultimate completion date of July 28, 2025, and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules (500-count units) on July 23, 2025, with a contract ceiling value of $1,193.52. This firm fixed-price delivery order represents a non-competitive set-aside, issued under the company's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 count) at a firm fixed price of $1,468.32, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.67 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 6, 2025, to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,594,942 units of Omeprazole DR 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $2,456.24 and an ultimate completion date of April 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,605,047 units of the pharmaceutical product Omeprazole DR 40 mg capsules. The contract has a completion date of February 9, 2024 and a potential value of $1,244.88. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,294.37 contract is for the delivery of 1,000 units of 40 milligram omeprazole delayed release capsules, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,036.32, is a delivery order for 4,566,874,691 units of omeprazole DR 40 mg capsules. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJKKDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,018.32 delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 omeprazole DR 40 mg capsules, with an ultimate completion date of August 26, 2025. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The omeprazole supply supports federal medical procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its critical role as a pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles supporting diverse therapeutic domains and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/25/25 |